Vfend and dyspnoea Patient Reports February 12, 2012

Vfend Side Effects Report #4921188-X
Vfend side effect was reported by a Physician from JAPAN on Feb 07, 2006. Male patient, 79 years of age, weighting 77.16 lb, was diagnosed with pulmonary mycosis, ill-defined disorder and was treated with Vfend. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, blood glucose increased, blood pressure immeasurable, bradycardia, cardiac arrest , dyspnoea, haemoglobin decreased. Vfend dosage: 400 MG INTRAVENOUS. During the same period patient was treated with CIPROFLOXACIN HYDROCHLORIDE, CLARITHROMYCIN, HABEKACIN, MICAFUNGIN, MUCOSTA. Patient was hospitalized. Patient died on 09/17/2005.

Vfend Side Effects Report #5375541-3
Vfend side effect was reported by a Consumer or non-health professional from UNITED STATES on June 19, 2007. Female patient, weighting 65.14 lb, was diagnosed with prophylaxis, aspergillosis and was treated with Vfend. After drug was administered, patient experienced the following side effects: aspergillosis, dyspepsia, dyspnoea, gastrointestinal tube insertion, gastrooesophageal reflux disease, obliterative bronchiolitis, oxygen saturation decreased. Vfend dosage: unknown. Patient was hospitalized. Patient recovered.

Vfend Side Effects Report #5460888-2
Vfend side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 25, 2007. Female patient, 79 years of age, weighting 110.0 lb, was diagnosed with fungal infection  and was treated with Vfend. After drug was administered, patient experienced the following side effects: asthenia, dyspnoea, feeling jittery, heart rate irregular, hypersensitivity. Vfend dosage: 400 MG (200 MG, 2 IN 1 D), ORAL. Patient was hospitalized. Patient recovered.

Vfend Side Effects Report #4783667-8
Vfend side effect was reported by a Physician from JAPAN on Sept 15, 2005. Male patient, 79 years of age, was diagnosed with bronchopulmonary aspergillosis, ill-defined disorder and was treated with Vfend. After drug was administered, patient experienced the following side effects: bradycardia, cardiac arrest , dyspnoea, encephalopathy, hypoglycaemia, loss of consciousness, malaise, mental disorder, pyrexia. Vfend dosage: 400 MG, INTRAVENOUS. During the same period patient was treated with CIPROXAN CIPROFLOXACIN). Patient recovered.


Vfend Side Effects Report #4788816-3
Vfend side effect was reported by a Physician from JAPAN on Sept 21, 2005. Male patient, 79 years of age, was diagnosed with bronchopulmonary aspergillosis, ill-defined disorder and was treated with Vfend. After drug was administered, patient experienced the following side effects: bradycardia, cardiac arrest , dyspnoea, encephalopathy, hypoglycaemia, loss of consciousness, malaise, mental disorder, pyrexia. Vfend dosage: 400 MG , INTRAVENOUS. During the same period patient was treated with CIPROFLOXACIN HYDROCHLORIDE. Patient died on 09/01/2005.

Vfend Side Effects Report #4803532-7
Vfend side effect was reported by a Physician from JAPAN on Oct 04, 2005. Male patient, 79 years of age, was diagnosed with bronchopulmonary aspergillosis, ill-defined disorder and was treated with Vfend. After drug was administered, patient experienced the following side effects: bradycardia, cardiac arrest , dyspnoea, loss of consciousness, malaise, pyrexia, toxic induced encephalopathy. Vfend dosage: 400 MG INTRAVENOUS. During the same period patient was treated with CIPROFLOXACIN HYDROCHLORIDE, CLARITH. Patient died on 09/01/2005.

Vfend Side Effects Report #4821187-2
Vfend side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 21, 2005. Female patient, 61 years of age, weighting 148.0 lb, was diagnosed with bronchopulmonary aspergillosis and was treated with Vfend. After drug was administered, patient experienced the following side effects: chromatopsia, condition aggravated, dyspepsia, dyspnoea, psychomotor hyperactivity. Vfend dosage: 40 MG (20 MG, 2 IN 1 D). During the same period patient was treated with AMIKACIN, ITRACONAZOLE, LORATADINE, METHYLPREDNISOLONE, CLONIDINE, BENADRYL, VITAMIN, VITAMIN A. Patient recovered.

Vfend Side Effects Report #5131089-2
Vfend side effect was reported by a Physician from UNITED STATES on Jan 30, 2006. Female patient, 58 years of age, weighting 185.0 lb, was diagnosed with bronchopulmonary aspergillosis, hypertension and was treated with Vfend. After drug was administered, patient experienced the following side effects: blood pressure decreased, blood pressure increased, confusional state, dizziness , dyspnoea, heart rate decreased, sensory disturbance, therapeutic response unexpected, visual disturbance. Vfend dosage: 400 MG (200 MG , 2 IN 1 D), ORAL. During the same period patient was treated with CLONIDINE, HYDROCHLOROTHIAZIDE, ALBUTEROL, ADVAIR DISKUS, FLONASE, MAGNESIUM, CORAL CALCIUM, CYSTEINE. Patient was hospitalized. Patient recovered.

Vfend Side Effects Report #5003210-8
Vfend side effect was reported by a Consumer or non-health professional from GERMANY on Apr 27, 2006. Male patient, 36 years of age, was diagnosed with bronchopulmonary aspergillosis and was treated with Vfend. After drug was administered, patient experienced the following side effects: bronchial obstruction, burning sensation, dyspnoea, haemoptysis, hypersensitivity, mucous membrane disorder, respiratory disorder, vital capacity decreased. Vfend dosage: 400 MG, ORAL. During the same period patient was treated with AMPHOTERICIN B. Patient recovered.


Vfend Side Effects Report #5038619-X
Vfend side effect was reported by a Physician from GERMANY on June 08, 2006. Male patient, 36 years of age, weighting 222.7 lb, was diagnosed with bronchopulmonary aspergillosis and was treated with Vfend. After drug was administered, patient experienced the following side effects: bronchial obstruction, burning sensation, dysaesthesia, dyspnoea, haemoptysis, hypersensitivity, mucous membrane disorder. Vfend dosage: 400 MG, ORAL. During the same period patient was treated with AMPHOTERICIN B, PREDISOLON, THEOPHYLLINE, FLUTIDETE. Patient recovered.

Vfend Side Effects Report #5360902-9
Vfend side effect was reported by a Physician from UNITED STATES on June 04, 2007. Female patient, weighting 119.9 lb, was diagnosed with bronchopulmonary aspergillosis, fungal infection  and was treated with Vfend. After drug was administered, patient experienced the following side effects: aspergillosis, asthma , dyspnoea, heart rate irregular, pneumonia bacterial, respiratory failure. Vfend dosage: unknown. During the same period patient was treated with ACCOLATE, LOVENOX, PROTONIX, LISINOPRIL, NORVASC, PLAVIX, LEVAQUIN. Patient was hospitalized. Patient recovered.

Vfend Side Effects Report #5818338-X
Vfend side effect was reported by a Physician from JAPAN on July 10, 2008. Male patient, weighting 121.3 lb, was diagnosed with bronchopulmonary aspergillosis and was treated with Vfend. After drug was administered, patient experienced the following side effects: dyspnoea, lung disorder. Vfend dosage: DAILY DOSE:400MG. Patient was hospitalized. Patient recovered.

Vfend Side Effects Report #5842499-X
Vfend side effect was reported by a Physician from JAPAN on July 31, 2008. Male patient, weighting 121.3 lb, was diagnosed with bronchopulmonary aspergillosis and was treated with Vfend. After drug was administered, patient experienced the following side effects: dyspnoea, graft versus host disease, hepatic enzyme increased, interstitial lung disease, rectal haemorrhage, respiratory tract infection. Vfend dosage: DAILY DOSE:400MG. Patient was hospitalized. Patient died on 07/22/2008.

Vfend Side Effects Report #5851942-1
Vfend side effect was reported by a Physician from JAPAN on Aug 08, 2008. Male patient, weighting 121.3 lb, was diagnosed with bronchopulmonary aspergillosis and was treated with Vfend. After drug was administered, patient experienced the following side effects: dyspnoea, graft versus host disease, hepatic enzyme increased, interstitial lung disease, rectal haemorrhage, respiratory tract infection. Vfend dosage: DAILY DOSE:400MG. Patient was hospitalized. Patient died on 07/22/2008.


Vfend Side Effects Report #6013827-X
Vfend side effect was reported by a Physician from KOREA, REPUBLIC OF on Dec 08, 2008. Female patient was diagnosed with bronchopulmonary aspergillosis, pneumonia , diabetes mellitus, prophylaxis against gastrointestinal ulcer, immunosuppression and was treated with Vfend. After drug was administered, patient experienced the following side effects: condition aggravated, dyspnoea, septic shock. Vfend dosage: 200 MG, 2X/DAY. During the same period patient was treated with SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFAMETHOXAZOLE AND TRIMETHOPRIM, METFORMIN, FAMOTIDINE, VOGLIBOSE, CYCLOSPORINE, TRIMAPRIM. Patient recovered.

Vfend Side Effects Report #5127562-3
Vfend side effect was reported by a Physician from JAPAN on Sept 25, 2006. Male patient, 71 years of age, weighting 111.1 lb, was diagnosed with bacterial infection  and was treated with Vfend. After drug was administered, patient experienced the following side effects: bacterial infection , condition aggravated, dyspnoea, interstitial lung disease, lung infiltration, metastases to bone, metastases to lung, multiple myeloma , oxygen saturation decreased. Vfend dosage: 140 MG (2 IN 1 D), INTRAVENOUS. During the same period patient was treated with PURSENNID, OMEPRAZOLE, TAMSULOSIN, LOXONIN, APLACE, MAGNESIUM OXIDE, TETRAMIDE. Patient was hospitalized. Patient died on 08/25/2006.

Vfend Side Effects Report #4830578-5
Vfend side effect was reported by a Physician from FRANCE on Nov 03, 2005. Female patient, 15 years of age, was diagnosed with aspergillosis, ill-defined disorder, nausea  and was treated with Vfend. After drug was administered, patient experienced the following side effects: anxiety , cardiac arrest , chest discomfort, dyspnoea, electrocardiogram qt prolonged, hypomagnesaemia, malaise, mucormycosis. Vfend dosage: 600 MG (300 MG, 2 IN 1 D), INTRAVENOUS. During the same period patient was treated with POSACONAZOLE, IMIDAZOLE SALICYLATE, OMEPRAZOLE, AMBISOME, CANCIDAS, MYCOSTATIN, AMPHOTERICIN B. Patient was hospitalized. Patient recovered.

Vfend Side Effects Report #4868779-2
Vfend side effect was reported by a Physician from FRANCE on Dec 12, 2005. Female patient, 15 years of age, was diagnosed with aspergillosis, ill-defined disorder, nausea  and was treated with Vfend. After drug was administered, patient experienced the following side effects: anxiety , cardiac arrest , chest discomfort, dyspnoea, electrocardiogram qt prolonged, hypomagnesaemia, malaise, mucormycosis. Vfend dosage: 600 MG (300 MG, 2 IN 1 D), INTRAVENOUS. During the same period patient was treated with POSACONAZOLE, IMIDAZOLE SALICYLATE, OMEPRAZOLE, AMBISOME, CANCIDAS, MYCOSTATIN, AMPHOTERICIN B. Patient was hospitalized. Patient recovered.

Vfend Side Effects Report #4943830-X
Vfend side effect was reported by a Physician from FRANCE on Feb 27, 2006. Female patient, 15 years of age, was diagnosed with aspergillosis, ill-defined disorder, nausea  and was treated with Vfend. After drug was administered, patient experienced the following side effects: anxiety , cardiac arrest , cardiovascular disorder, dyspnoea, electrocardiogram qt prolonged, hypomagnesaemia, malaise, pallor. Vfend dosage: 600 MG (300 MG, 2 IN 1 D), INTRAVENOUS. During the same period patient was treated with POSACONAZOLE, IMIDAZOLE SALICYLATE, OMEPRAZOLE, AMBISOME, CANCIDAS, MYCOSTATIN, AMPHOTERICIN B, NYSTATINE. Patient was hospitalized. Patient recovered.


Vfend Side Effects Report #5384743-1
Vfend side effect was reported by a Physician from CHINA on July 03, 2007. Female patient, 27 years of age, was treated with Vfend. After drug was administered, patient experienced the following side effects: anoxia, dyspnoea. Vfend dosage: unknown. Patient recovered.